T Papajík Selected Research

Stanford V protocol

1/2007

[Chemotherapy of BOVAPEC in the primary treatment of Hodgkin's lymphoma intermediate stages].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Papajík Research Topics

Disease

3	Hodgkin Disease (Hodgkin's Disease) 11/2016 - 02/2002
1	Neoplasms (Cancer) 01/2006
1	Hairy Cell Leukemia 05/2002
1	Hepatolenticular Degeneration (Wilson's Disease) 04/2002
1	Hemolytic-Uremic Syndrome 04/2002
1	Thrombotic Thrombocytopenic Purpura 04/2002
1	Lymphoma (Lymphomas) 01/2001
1	Residual Neoplasm 01/2001

Drug/Important Bio-Agent (IBA)

1	pembrolizumabIBA 11/2016
1	Bendamustine Hydrochloride FDA Link 11/2016
1	NivolumabIBA 11/2016
1	Brentuximab VedotinIBA 11/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	Cladribine FDA LinkGeneric 05/2002
1	CopperIBA 04/2002
1	thiamine triphosphorate (TTP)IBA 04/2002
1	AlbuminsIBA 02/2002
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2002
1	Rituximab (Mabthera)FDA Link 01/2001

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 11/2016 - 01/2001
1	Stem Cell Transplantation 11/2016
1	Stanford V protocol 01/2007
1	Therapeutics 01/2001
1	Autologous Transplantation 01/2001
1	Immunotherapy 01/2001